title: [Heparin-induced thrombocytopenia type II: a clinically relevant problem?].
authors.affiliation: Institut für Transfusionsmedizin und Immunhämatologie, Universität Magdeburg, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Böck
authors.forename: I
authors.initials: I
authors.lastname: Woitzyk
authors.forename: M S
authors.initials: MS
authors.lastname: Jepsen
authors.forename: J
authors.initials: J
authors.lastname: Molling
authors.forename: T
authors.initials: T
authors.lastname: Welte
authors.forename: K
authors.initials: K
authors.lastname: Leimkühler
authors.forename: M U
authors.initials: MU
authors.lastname: Heim
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D015539:Platelet Activation / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects; D012307:Risk Factors; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*
chemical_list: D000925:Anticoagulants; D006493:Heparin